Health care company Abbott committed to SFDA vision

Abbott was the official sponsor for this year’s Saudi Food and Drug Authority Conference and Exhibition 2019.
Updated 07 October 2019

Health care company Abbott committed to SFDA vision

Health care company Abbott was the official sponsor for this year’s Saudi Food and Drug Authority Conference and Exhibition (SFDACE) 2019. The conference theme was “Consumer Engagement and Consumer-Centered Regulations” and took place between Sept. 30 and Oct. 2 in Riyadh.

Through this sponsorship, Abbott aimed at maintaining and enhancing its presence in the Kingdom and highlighting its range of innovative health care products. This goes in line with the advances introduced in the Ministry of Health’s strategic health plan, as part of Saudi Vision 2030. 

Abbott General Manager in Saudi Arabia Imad Mousa said: “We were delighted to participate in the SFDACE event for the third consecutive year. Our aim is to continue to support the Kingdom’s strategic health plan and work alongside the Ministry of Health in order to raise health care standards. We are proud of our long history in the Kingdom which extends over more than 75 years. During this time, we have introduced a wide range of life-changing technologies and products that have played an important role in improving people’s lives.”

Abbott had a dedicated booth at the SFDA’s exhibition where it showcased its latest innovative medical solutions. The company also participated in panel discussions and workshops, discussing medical devices clinical trials and highlighting the latest medical technology that protects patients. 

Dr. Yana Pozhidaeva, associate director clinical quality assurance at Abbott, gave a workshop on “Generation of Clinical Evidence for Medical Devices,” whereas Samir Shah, divisional vice president for software product development, gave a presentation on “Cardiac Device Cybersecurity — Commitment to Patient Protection.”

Abbott has been a fervent advocate of the Saudization program. As part of its commitment to Saudization, 40 percent of the company’s medical representatives who joined its pharmaceuticals division this year were Saudis, with plans to have a 100 percent Saudi sales force within the division by 2021. 

The company also launched a university relations program, with four different universities and colleges across the Kingdom. 

By virtue of the program, Abbott collaborates with these academic institutions to hold summer training programs and yearly internship waves for students to increase their awareness of potential career options in the health care sector.


Production of Aston Martin DB5 resumes after 55 years

Updated 38 min 43 sec ago

Production of Aston Martin DB5 resumes after 55 years

Dubbed “the most famous car in the world” and renowned as being among the most sought-after classic Aston Martin models, the DB5 has become a byword for timeless style and sports car desirability. Fewer than 900 saloon examples were built by the brand between 1963 and 1965, with by far the most famous of the original owners being the world’s best-known secret agent — James Bond — who first drove the car that is today inextricably linked with him in the 1964 film, Goldfinger.

Now, 55 years after the last new DB5 rolled off the production line at Aston Martin’s then-global manufacturing base in Newport Pagnell, Buckinghamshire, work is once again underway there on a strictly limited number of new DB5 models. Created in association with the producers of the James Bond films, EON Productions, and featuring a broad suite of working gadgets first seen on screen in the 1964 film, the Aston Martin DB5 Goldfinger Continuation cars are history in the making.

Each DB5 Goldfinger continuation car is priced at 2.75 million euros ($3.05 million), plus taxes.

The DB5 Goldfinger Continuation construction process — which takes around 4,500 hours per car — is being undertaken at Aston Martin’s Heritage Division headquarters in Newport Pagnell, Buckinghamshire.

Each of the 25 new cars is being built using a blend of Sir David Brown-era old world craftsmanship, with the application of modern engineering advancements and performance enhancements, alongside the integration of cutting-edge gadgets developed in association with Chris Corbould OBE, the special effects supervisor who has worked on more than a dozen Bond films.

Clive Wilson, Heritage program manager, said: “Seeing the first customer car move painstakingly through the intricate production process we have created really is quite a thrill.

“Obviously we have not, as a business, made a new DB5 for more than 50 years, so to be involved in the building of these cars, which will go on to form part of Aston Martin’s history, is something I’m sure all of us will be telling our grandkids about!”

Paul Spires, president of Aston Martin Works where the original DB5 was built and the new cars are also being created, said: “We are making, perhaps, some of the most desirable ‘toys’ ever built for 25 very lucky buyers worldwide.

“Creating the DB5 Goldfinger Continuation cars and working with EON Productions and special effects supervisor, Chris Corbould, is something truly unique and a real career highlight for everyone involved here at Aston Martin Works.”

First deliveries of the DB5 Goldfinger Continuation to customers will commence in the second half of 2020.